Prokidney to participate in two upcoming conferences: evercore healthconx conference and the citi global healthcare conference

Winston-salem, n.c., nov. 26, 2024 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney”), a late clinical-stage biotech company focused on the development of a first-in-class cell therapy candidate for chronic kidney disease (ckd), today announced that senior members of the management team will be participating in the following two upcoming healthcare conferences in december:
prok Ratings Summary
prok Quant Ranking